PH big-ticket hospital PPPs up for bids

Bidding for these projects may commence in the first half of 2022.

Big-ticket healthcare public-private partnership (PPP) projects are coming to the Philippines this year, paving the way for needed hospital capacity in Metro Manila.

According to the PPP Center, it has readied the bidding for a new Philippine General Hospital (PGH) in Quezon City and a 300-bed PGH cancer centre in Manila. The two projects will be implemented by the University of the Philippines.

"Once approved, bidding for these critical health infrastructure projects may commence in the early quarters of 2022," the PPP Center said in the statement to the Philippine Daily Inquirer.

The integrated healthcare facility in Quezon City will include a 700-bed university teaching and research hospital, a college of medicine, and a genomic cancer research centre. Meanwhile, the PGH cancer centre will be a specialized facility dedicated to treating underprivileged Filipinos.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The loss will not have any material impact on the company.
Around 66 hotels have submitted to offer their rooms for hotel isolation.
He has been acting as group CEO since September 2021.
Bidding for these projects may commence in the first half of 2022.
Cardholders can now seek treatment from units where they did not register.
The system will be implemented this year.
The new facility will provide care for Indonesians who get treatment overseas.
The system was the only one of its kind in the country.
Healthcare Asia will be back on 3 January 2022. 
The additional patents aim to address supply issues.
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
Despite NCDs accounting for 41 million deaths annually, they are still healthcare's 'blind spot', expert says.
The gala was held in celebration of World AIDS Day 2021.
It won in the International Human-Machine Competition on Diabetes Management.
The new facility is the first of its kind in Singapore.